A Aralex Aachen research explorer

September 24, 2019 article Open access

Prospective CYP2C19‐Guided Voriconazole Prophylaxis in Patients With Neutropenic Acute Myeloid Leukemia Reduces the Incidence of Subtherapeutic Antifungal Plasma Concentrations

Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.1641 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 2 stored of 40

Development of a dosing algorithm integrating pharmacogenetic markers and inflammation for individualization of initial voriconazole maintenance doses
2026 Antimicrobial Agents and Chemotherapy article Medicine Antifungal resistance and susceptibility Open access

0

citations
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
2024 Clinical and Translational Science article Pharmacology, Toxicology and Pharmaceutics Pharmacogenetics and Drug Metabolism Open access

15

citations

2 results

References 0